Clover Health Investments, Corp.
corporate_fare Company Profile
Clover Health Investments, Corp. (NASDAQ:CLOV) is a publicly traded company in the Finance sector. Wiseek has independently scored 26 items for CLOV at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-06, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 13 rated 8 or above. Recent SEC coverage for CLOV spans 10-Q, 8-K, 144, DEF 14A.
Recent high-impact activity:
- Clover 10-Q: Q3 Net Income $6.4M, Nine-Month Profit $61.8M, Cash $512.6M
- Clover Health Posts $6.4M Q3 Profit, Raises Full-Year 2026 Guidance Across All Metrics
- Clover Health Tops Q3 Estimates With $759M Revenue and $16M Adjusted EBITDA
- Clover Health PPO Plans Land 5-Star CMS Rating, Unlocking Year-Round Enrollment
- Clover Health Swings to Profit in Q2, Raises Full-Year Outlook on Membership Surge
Financial Snapshot
Short Interest & Short Volume
6.73 days to coverFINRA reported short interest of 23,025,747 shares in CLOV as of the October 30, 2026 settlement, a 11.3% decrease from the prior period — about 6.7 days to cover at its recent average daily volume. On November 19, 2026, 50.8% of CLOV volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.